Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board

Authors

Andrew Blauvelt, Blauvelt Consulting, LLC, Annapolis, Maryland, USA. Electronic address: blauveltconsults@gmail.com.
Ronald Prussick, George Washington University, Washington, District of Columbia, USA.
Joseph F. Merola, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Mona Shahriari, Central CDT Dermatology, Cromwell, Connecticut, USA.
Jennifer Cather, Mindful Dermatology and Modern Research Associates, Dallas, Texas, USA.
Guy S. Eakin, National Psoriasis Foundation, Alexandria, Virginia, USA.
Leah McCormick Howard, National Psoriasis Foundation, Alexandria, Virginia, USA.
Mark G. Lebwohl, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
April W. Armstrong, University of California Los Angeles, Los Angeles, California, USA.
Kristina Callis Duffin, University of Utah, Salt Lake City, Utah, USA.

Document Type

Journal Article

Publication Date

12-30-2025

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2025.12.087

Keywords

psoriasis; public policy

APA Citation

Blauvelt, Andrew; Prussick, Ronald; Merola, Joseph F.; Shahriari, Mona; Cather, Jennifer; Eakin, Guy S.; McCormick Howard, Leah; Lebwohl, Mark G.; Armstrong, April W.; and Duffin, Kristina Callis, "Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board" (2025). GW Authored Works. Paper 8349.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8349

Department

Dermatology